Latest Industry Insights
Industry Insight
Analyzing Sperm DNA Damage To Diagnose Male Infertility
A recent collaborative study between Examen and the Lister Fertility Clinic in London used Examen’s COMET assay to measure sperm DNA damage in men with unexplained infertility. We spoke with Professor Sheena Lewis, CEO of Examen, to learn more about the study, the links between sperm DNA damage and infertility, and the value of adding this parameter to fertility testing.
Industry Insight
Translational Research in Clinical Proteomics
In this article, Gary Kruppa, VP of Proteomics at Bruker Daltonics, explores how proteomic methods can help achieve the ultimate goal of preventing and improving the treatment of disease.
Industry Insight
Fighting Neurodegeneration by Understanding Inflammation
Neurodegenerative diseases are one of the most pressing challenges of our time and teasing out the cellular mechanisms underpinning these diseases is a key goal for researchers in the field. We talked to Stéphane Martinez of CISBIO to discuss how researchers can access information on neurodegenerative mechanisms and how we are beginning to recognize the contribution of the immune system to neurodegeneration.
Industry Insight
A Conversation on the "Latest and Greatest" in Metabolomics
Aided by advances in high-throughput technologies, the metabolomics research field has gained significant traction. We spoke with Baljit Ubhi, Ph.D. from SCIEX, about the recent developments in metabolomics, addressing the increasing focus on the microbiome, how it impacts metabolic disease, and the future directions of research, including "precision nutrition".
Industry Insight
Applying Precision Genomics in Biopharma Drug Development
A recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.
Industry Insight
First-of-Its-Kind Lipidomics Excellence Award Acknowledges Forward-thinking in a Rapidly Growing Field
Technology Networks recently visited Dresden, Germany, for Lipotype's Lipid Excellence Award press talk, where we gained insights into the past, present and future of lipidomics research.
Industry Insight
Food Poisoning Bacteria’s Sugar Coating Could Be Its Undoing
To learn how Campylobacter hides from the body’s immune system, why some people are more susceptible than others, and the potential role that carbohydrate-based diagnostics could play in the fight against the bacterium, we spoke to Professor Rob Field, Co-founder of Iceni Diagnostics.
Industry Insight
Exploring the Fourth Dimension of Proteome Analysis
Recent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.
Industry Insight
Clinical Proteomics and Computational Biochemistry With Professor Jürgen Cox
Technology Networks recently spoke with Professor Jürgen Cox to learn more about the computational software tools his laboratory are developing, and how 4D proteomics workflows enhance research in clinical proteomics.
Industry Insight
Talking Clinical Proteomics With Dr Roman Fischer
Technology Networks spoke with Dr Roman Fischer to learn more about the challenges researchers face in the field of clinical proteomics, and how 4D proteomics workflows are enhancing his laboratory's work.
Advertisement